INTERVENTIONAL TREATMENT OF CORONARY HEART DISEASEIN PREVENTION OF SUDDEN CARDIAC DEATH

Cover Page


Cite item

Full Text

Abstract

Sudden cardiac death - a non-violent death, which developed instantly or within one hour from the time of acute changes in the clinical status of patient, which is based on cardiac causes. The main cause of SCD is coronary heart disease, which accounts for 80% of all cases. More than half of that cases are associated with acute disorders of the coronary circulation. Sudden cardiac death is a leading cause of mortality in patients with coronary artery disease. All activities that improve the prognosis in patients with coronary artery disease, reduce the risk of sudden cardiac death. Methods of direct myocardial revascularization allowed to improve radically the quality of life and prognosis in patients with coronary artery disease. Interventional treatment is highly effective and widely used method of direct myocardial revascularization, plays a crucial role in improving life expectancy of patients with ischemic heart disease, including through the prevention of sudden cardiac death.

About the authors

A V Staferov

Email: avstaferov@mail.ru

A V Sorokin

References

  1. Шляхто Е.В., Арутюнов Г.П., Беленков Ю.Н. с соавт. Национальные рекомендации по определению риска и профилактике внезапной сердечной смерти. Москва, издательство "Медпрактика-М". 2013.
  2. Zipes D.P., Camm A.J., Borggrefe M. et al. ACC/AHA/ESC 2006 Guidelines for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Death. J Am Coll Cardiol 2006; 48:1064-1108.
  3. Myerburg R.J., Junttila M.J. Sudden Cardiac Death Caused by Coronary Heart Disease. Circulation 2012; 125:1043-1052.
  4. Bougouin W., Marijon E., Puymirat E. et al. Incidence of sudden cardiac death after ventricular fibrillation complicating acute myocardial infarction: a 5-year cause-of-death analysis of the FAST-MI 2005 registry. Eur Heart J 2014; 35:116-22.
  5. Zaman S., Narayan A., Thiagalingam A. et al. What is the optimal left ventricular ejection fraction cut-off for risk stratification for primary prevention of sudden cardiac death early after myocardial infarction? Europace 2014; 16:1315-21.
  6. Vasiliadis I., Kolovou G., Mavrogeni S. et al. Sudden cardiac death and diabetes mellitus. J Diabetes Complications 2014; 28:573-79.
  7. O'Shaughnessy M.M., O'Regan J.A., Lavin P. Prevention of Sudden Cardiac Death in Hemodialysis Patients. Cardiovasc Hematol Disord Drug Targets 2014; 14:195-204.
  8. Бокерия Л.А., Гудкова Р.Г. Сердечно-сосудистая хирургия-2012. Болезни и врожденные аномалии системы кровообращения. Москва, НЦССХ им. А.Н. Бакулева РАМН. 2013.
  9. Stefanini G.G., Holmes D.R. Jr. Drug-Eluting Coronary-Artery Stents. N Engl J Med 2013; 368:254-65.
  10. Epstein A.J., Polsky D., Yang F. et al. Coronary Revascularization Trends in the United States, 2001-2008. JAMA 2011; 305:1769-76.
  11. Wijns W., Kolh P., Danchin N. et al. Guidelines on myocardial revascularization. Eur Heart J 2010; 31:2501-55.
  12. Patel M.R., Dehmer G.J., Hirshfeld J.W. et al. Appropriate Use Criteria for Coronary Revascularization Focused Update. J Am Coll Cardiol 2012; 59:857-81.
  13. Бокерия Л.А., Алекян Б.Г. Рентгенэндоваскулярная диагностика и лечение заболеваний сердца и сосудов в Российской Федерации, 2012 год. Москва, НЦССХ им. А.Н. Бакулева РАМН. 2013.
  14. Widimsky P., Wijns W., Fajadet J. et al. Reperfusion therapy for ST elevation acute myocardial infarction in Europe: description of the current situation in 30 countries. Eur Heart J 2010; 31:943-57.
  15. Gotsman M.S., Lewis B.S., Bakst A. Obstruction of the LMCA - the artery of sudden death. S Afr Med J 1973;.47:641-44.
  16. Saint-Pierre A., Amiel M., Jamet C. et al. Significance of atheromatous stenoses of the common trunk of the left coronary artery. Arch Mal Coeur Vaiss 1974; 67:1305-15.
  17. Erbel R., Wijns W. The year in cardiology 2013; coronary interventions. Eur Heart J 2014; 35:313-20.
  18. Claessen BE, Stone GW, Smits PC, et al. Would SYNTAX have been a positive trial if XIENCE V had been used instead of TAXUS?: A meta-analysis of a first-generation vs. a second-generation drug-eluting stent system. Neth Heart J 2010; 18:451-53.
  19. Tonino P.A., Fearon W.F., De Bruyne B. et al. Angiographic versus functional severity of coronary artery stenoses in the FAME study fractional flow reserve versus angiography in multivessel evaluation. J Am Coll Cardiol 2010; 55:2816-21.
  20. Pijls N.H., Fearon W.F., Tonino P.A., et al. Fractional flow reserve versus angiography for guiding percutaneous coronary intervention in patients with multivessel coronary artery disease: 2-year follow-up of the FAME (Fractional Flow Reserve Versus Angiography for Multivessel Evaluation) study. J Am Coll Cardiol 2010; 56:177-84.
  21. Godino C., Bassanelli G., Economou F.I. et al. Predictors of cardiac death in patients with coronary chronic total occlusions not revascularized by PCI. Int J Cardiol 2013; 168:1402-9.
  22. Tagaki K., Ielasi A., Chieffo A. et al. Impact of residual chronic total occlusion of right coronary artery on the long-term outcome in patients treated for unprotected left main disease: the Milan and New-Tokyo registry. Circ Cardiovasc Interv 2013; 6: 154-60.
  23. Fihn S.D., Gardin J.M., Abrams J. et al. 2012 ACCF/AHA/ACP/AATS/PCNA/SCAI/STS Guideline for the Diagnosis and Management of Patients With Stable Ischemic Heart Disease. J Am Coll Cardiol 2012; 60:e44-e164.
  24. Levine G.N., Bates E.R., Blankenship J.C. et al. 2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention. J Am Coll Cardiol 2011; 58:e44-122.
  25. O'Gara P.T., Kushner F.G., Ascheim D.D. et al. 2013 ACCF/AHA Guideline for the Management of ST-Elevation Myocardial Infarction. J Am Coll Cardiol 2013; 61:e78-140.
  26. Kristensen S.D., Fajadet J., Di Mario C. Implementation of primary angioplasty in Europe: Stent for Life initiative progress report. EuroIntervention 2012; 8:35-42.
  27. Anderson J.L., Adams C.D., Antman E.M. et al. 2012 ACCF/AHA Focused Update Incorporated Into the ACCF/AHA 2007 Guidelines for the Management of Patients With Unstable Angina/ Non-ST-Elevation Myocardial Infarction. J Am Coll Cardiol 2013; 61: 79-347.
  28. Jorgensen E., Kelbak H. It's time to say good-bye.. (to the first-generation drug-eluting stent era). EuroIntervention 2012; 7:1011-13.
  29. Iqbal J., Onuma Y., Ormiston J. et al. Bioresorbable scaffolds: rationale, current status, challenges and future. Eur Heart J 2014; 35:765-76.

Supplementary files

Supplementary Files
Action
1. JATS XML
Download

Copyright (c) 2014 Staferov A.V., Sorokin A.V.

Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
СМИ зарегистрировано Федеральной службой по надзору в сфере связи, информационных технологий и массовых коммуникаций (Роскомнадзор).
Регистрационный номер и дата принятия решения о регистрации СМИ: серия ПИ № ФС 77 - 38032 от 11 ноября 2009 года.


This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies